Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00564_DB00755_nanopub.RAYp6EyRn0TM--ZddDU-Z_Z05C_AddPWvZzaZFMCO3bgk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00564_DB00755 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00564_DB00755 label "DDI between Carbamazepine and Tretinoin - The strong CYP2C8 inducer, Carbamazepine, may increase the metabolism and clearance of oral Tretinoin. Consider alternate therapy to avoid failure of Tretinoin therapy or monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Carbamazepine is initiated, discontinued or dose changed. [drugbank_resource:DB00564_DB00755]" assertion.
- drugbank_resource:DB00564_DB00755 identifier "drugbank_resource:DB00564_DB00755" assertion.
- drugbank_resource:DB00564_DB00755 title "DDI between Carbamazepine and Tretinoin - The strong CYP2C8 inducer, Carbamazepine, may increase the metabolism and clearance of oral Tretinoin. Consider alternate therapy to avoid failure of Tretinoin therapy or monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Carbamazepine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00564 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00564_DB00755 assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00564_DB00755 assertion.